Compare ONC & MTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ONC | MTB |
|---|---|---|
| Founded | 2010 | 1856 |
| Country | Switzerland | United States |
| Employees | 12000 | 21866 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.4B | 29.9B |
| IPO Year | N/A | N/A |
| Metric | ONC | MTB |
|---|---|---|
| Price | $268.53 | $225.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 17 |
| Target Price | ★ $385.10 | $228.59 |
| AVG Volume (30 Days) | 257.0K | ★ 932.3K |
| Earning Date | 05-06-2026 | 04-15-2026 |
| Dividend Yield | N/A | ★ 2.78% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $723.76 | $9.87 |
| Revenue Next Year | $15.04 | $3.66 |
| P/E Ratio | $614.06 | ★ $13.63 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $239.25 | $174.76 |
| 52 Week High | $385.22 | $239.00 |
| Indicator | ONC | MTB |
|---|---|---|
| Relative Strength Index (RSI) | 39.72 | 57.94 |
| Support Level | $253.95 | $211.90 |
| Resistance Level | $323.73 | $233.52 |
| Average True Range (ATR) | 7.22 | 4.51 |
| MACD | -0.37 | 0.56 |
| Stochastic Oscillator | 44.16 | 66.96 |
BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.
M&T Bank is a US regional bank with around $215 billion in assets as of the end of the first quarter of 2026. Headquartered in Buffalo, New York, the bank's footprint is mostly concentrated in New England and the US Mid-Atlantic. M&T Bank boasts a community banking approach, and boasts over 900 branches in 13 states and Washington, D.C. Apart from retail and commercial banking, M&T Bank also has wealth management operations through Wilmington Trust and a partnership with LPL Financial, and a corporate trust business.